Drug Profile
IBCH 05
Latest Information Update: 04 Oct 2019
Price :
$50
*
At a glance
- Originator Pharma Bio LLC
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Anxiety disorders
Most Recent Events
- 04 Oct 2019 Discontinued - Phase-II for Anxiety disorders in Russia (unspecified route)
- 01 Mar 2016 Phase-II clinical trials in Anxiety disorders in Russia (unspecified route)